Immunosuppression of experimental autoimmune myasthenia gravis by azathioprine. II. Evaluation of immunological mechanism.
D000818:Animals; D000941:Antigens / Q000008:administration & dosage; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000209:etiology; D001379:Azathioprine / Q000494:pharmacology*; D007166:Immunosuppressive Agents; D066298:In Vitro Techniques; D008198:Lymph Nodes / Q000276:immunology; D008213:Lymphocyte Activation; D008264:Macrophages / Q000276:immunology; D009157:Myasthenia Gravis / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D011817:Rabbits; D011950:Receptors, Cholinergic
D000941:Antigens; D007166:Immunosuppressive Agents; D011950:Receptors, Cholinergic; D001379:Azathioprine